SMN deficiency in muscle stem cells causes their apoptosis, leading to neuromuscular junction remodeling and non-cell autonomous loss of motor neurons.
Does targeted knockdown of Smn in muscle stem cells induce loss of motor neurons in SMA models?
Depletion of muscle stem cells via SMN deficit leads to non-cell autonomous loss of motor neurons, suggesting muscle stem cells may be important therapeutic targets for SMA.
Abstract Spinal Muscular Atrophy (SMA) is due to a deficit in SMN, a ubiquitously expressed protein encoded by the Survival of Motor Neuron 1 (SMN1) gene. Recently, SMN-targeted disease modifying treatments have greatly improved the clinical outcomes of this neuromuscular disease. However, uncertainties remain regarding their long-term efficacy and non-neuronal tissue involvement in disease progression. Skeletal muscle tissue and the Muscle Stem Cells (MuSC) that sustain its postnatal growth and regenerative capacity, are affected by SMN deficit. While a direct contribution of muscle tissue in the disease progression has been demonstrated, the extent to which MuSC are involved in this process remains to be established. Using SMA type II patient muscle biopsies and several mutant mouse models, we performed an accurate study of SMN role in MuSC function during postnatal growth and adulthood. We found that SMA type II patient muscles display a reduced number of quiescent PAX7+ MuSC. In SMA mice, we showed that SMN is an important regulator of myogenic progenitor fate during early postnatal growth, and that SMN deficit compromises MuSC reservoir establishment. In Pax7 Cre-driven conditional knockout mouse models, we demonstrated that deletion of a single Smn allele is sufficient to induce quiescent MuSC apoptosis in adult muscle, showing that high levels of SMN are required for the maintenance of the quiescent MuSC reservoir. We further established that depletion of MuSC yielded neuromuscular junctions remodeling followed by a non-cell autonomous loss of part of the alpha motor neurons (MN) in the long term. Overall, our findings demonstrate an interdependence between quiescent MuSC and the MN reservoirs, supporting that MuSC may be important therapeutic targets for the long-term treatment of SMA. Moreover, we provide important insights into the specific SMN requirements of MuSC, which could be valuable for to the development of next generation combinatorial therapies.
Mecca et al. (2026) studied this question. SMN deficiency in muscle stem cells causes their apoptosis, leading to neuromuscular junction remodeling and non-cell autonomous loss of motor neurons.